UPDATE: Sterne Agee Initiates Coverage on Cardinal Health with Neutral Rating, $48 PT on Dominant Market Share


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


In a report published Thursday, Sterne Agee analyst Greg T. Bolan initiated coverage on

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Cardinal Health (NYSE: CAH) with a Neutral rating and $48.00 price target.In the report, Sterne Agee noted, “With dominant market share of the independent pharmacy drug distribution channel, we believe CAH's profitability will benefit from an acceleration in brand-to-generic conversion in CY14/15. However, with EPS growth in CY14 that should be inferior to that of its peers, we do not believe CAH shares will outperform the peer group over the NTM. We initiate with a Neutral rating and $48 price target.”Cardinal Health closed on Wednesday at $53.32.
Posted In: Analyst ColorInitiationAnalyst RatingsGreg T. BolanSterne Agee